The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment

Metastatic prostate cancer represents a yet unsolved clinical problem due to the high frequency of relapse and treatment resistance. Understanding the pathways that lead to prostate cancer progression is an important task to prevent this deadly disease. The ETS transcription factor ESE3/EHF has an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Albino, Domenico, Civenni, Gianluca, Rossi, Simona, Mitra, Abhishek, Catapano, Carlo V., Carbone, Giuseppina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363547/
https://www.ncbi.nlm.nih.gov/pubmed/27732936
http://dx.doi.org/10.18632/oncotarget.12525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363547/
https://www.ncbi.nlm.nih.gov/pubmed/27732936
http://dx.doi.org/10.18632/oncotarget.12525

Ejemplares similares